HEM Pharma Inc. (KOSDAQ:376270)

South Korea flag South Korea · Delayed Price · Currency is KRW
59,500
-1,500 (-2.46%)
At close: Apr 28, 2026
180.66%
Market Cap 437.75B
Revenue (ttm) 12.98B
Net Income (ttm) -23.84B
Shares Out 7.18M
EPS (ttm) -3,389.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 18,955
Average Volume 23,011
Open 61,600
Previous Close 61,000
Day's Range 58,800 - 61,700
52-Week Range 18,000 - 97,500
Beta n/a
RSI 40.18
Earnings Date May 28, 2026

About HEM Pharma

HEM Pharma Inc. operates as a microbiome healthcare company in South Korea and internationally. The company offers health functional food products, such as Nutrilite and my LAB microbiome solution. It also engages in the personalized analysis service and CDMO businesses. The company was founded in 2016 and is based in Pohang, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 2016
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 376270
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.